Nycomed Files NDA For Daxas; Still Seeks U.S. Marketing Partner For Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Daxas shows positive effect on exacerbations in patients with chronic obstructive pulmonary disease in pivotal studies; final data expected in September.